Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 33403 | 125 | 26.6 | 62% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 1 | 4 | ECONOMICS//EDUCATION & EDUCATIONAL RESEARCH//PSYCHOL | 3876184 |
| 267 | 3 | PALLIATIVE CARE//END OF LIFE CARE//PSYCHO-ONCOLOGY | 44147 |
| 228 | 2 | PSYCHO-ONCOLOGY//SHARED DECISION MAKING//SUPPORTIVE CARE IN CANCER | 20371 |
| 33403 | 1 | HYPOTHETICAL REGIMEN//ABSOLUTE SURVIVAL ADVANTAGE//AGIN STUDIES | 125 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | HYPOTHETICAL REGIMEN | authKW | 488569 | 2% | 100% | 2 |
| 2 | ABSOLUTE SURVIVAL ADVANTAGE | authKW | 244285 | 1% | 100% | 1 |
| 3 | AGIN STUDIES | address | 244285 | 1% | 100% | 1 |
| 4 | BREAST CANCER PATIENT CARE | authKW | 244285 | 1% | 100% | 1 |
| 5 | CANC CARE HAEMATOL UNIT | address | 244285 | 1% | 100% | 1 |
| 6 | CONTINUOUS HEALTH CARE | authKW | 244285 | 1% | 100% | 1 |
| 7 | COSTS VALUATION | authKW | 244285 | 1% | 100% | 1 |
| 8 | DECISION BOARD INSTRUMENT | authKW | 244285 | 1% | 100% | 1 |
| 9 | HOSPICE PALLIAT CARE END OF LIFE STUDIES | address | 244285 | 1% | 100% | 1 |
| 10 | MED NP | address | 244285 | 1% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Oncology | 1530 | 57% | 0% | 71 |
| 2 | Law | 172 | 7% | 0% | 9 |
| 3 | Social Sciences, Biomedical | 105 | 4% | 0% | 5 |
| 4 | Medicine, General & Internal | 100 | 14% | 0% | 18 |
| 5 | Health Care Sciences & Services | 99 | 6% | 0% | 8 |
| 6 | Nursing | 76 | 5% | 0% | 6 |
| 7 | Rehabilitation | 38 | 4% | 0% | 5 |
| 8 | Health Policy & Services | 21 | 2% | 0% | 3 |
| 9 | Surgery | 19 | 9% | 0% | 11 |
| 10 | Psychology, Multidisciplinary | 18 | 3% | 0% | 4 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | AGIN STUDIES | 244285 | 1% | 100% | 1 |
| 2 | CANC CARE HAEMATOL UNIT | 244285 | 1% | 100% | 1 |
| 3 | HOSPICE PALLIAT CARE END OF LIFE STUDIES | 244285 | 1% | 100% | 1 |
| 4 | MED NP | 244285 | 1% | 100% | 1 |
| 5 | MEDBREAST ONCOL PROGRAM | 244285 | 1% | 100% | 1 |
| 6 | OUCOL MED | 244285 | 1% | 100% | 1 |
| 7 | SERV NEUROONCOL NEUROCHIRURG | 244285 | 1% | 100% | 1 |
| 8 | SHANGHAI REP OFF | 244285 | 1% | 100% | 1 |
| 9 | SSWAHS AREA PALLIAT CARE SERV WESTERN ZONE | 244285 | 1% | 100% | 1 |
| 10 | SYDNEY CANC GH6 | 244285 | 1% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | ISSUES IN LAW & MEDICINE | 35307 | 5% | 2% | 6 |
| 2 | CLINICAL & TRANSLATIONAL ONCOLOGY | 1614 | 2% | 0% | 3 |
| 3 | JOURNAL OF CLINICAL ONCOLOGY | 1502 | 8% | 0% | 10 |
| 4 | CLINICAL BREAST CANCER | 1270 | 2% | 0% | 2 |
| 5 | CLINICAL JOURNAL OF ONCOLOGY NURSING | 1205 | 2% | 0% | 2 |
| 6 | EUROPEAN JOURNAL OF CANCER | 1195 | 6% | 0% | 7 |
| 7 | PSYCHO-ONCOLOGY | 874 | 2% | 0% | 3 |
| 8 | PATIENT-PATIENT CENTERED OUTCOMES RESEARCH | 829 | 1% | 0% | 1 |
| 9 | EUROPEAN JOURNAL OF CANCER CARE | 802 | 2% | 0% | 2 |
| 10 | EJC SUPPLEMENTS | 754 | 1% | 0% | 1 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | BLINMAN, P , MCLACHLAN, SA , NOWAK, AK , DURIC, VM , BROWN, C , WRIGHT, G , MILLWARD, M , FONG, K , STOCKLER, MR , (2011) LUNG CANCER CLINICIANS' PREFERENCES FOR ADJUVANT CHEMOTHERAPY IN NON-SMALL-CELL LUNG CANCER: WHAT MAKES IT WORTHWHILE?.LUNG CANCER. VOL. 72. ISSUE 2. P. 213-218 | 11 | 65% | 4 |
| 2 | BLINMAN, P , DURIC, V , NOWAK, AK , BEALE, P , CLARKE, S , BRISCOE, K , BOYCE, A , GOLDSTEIN, D , HUDSON, M , STOCKLER, M , (2010) ADJUVANT CHEMOTHERAPY FOR EARLY COLON CANCER: WHAT SURVIVAL BENEFITS MAKE IT WORTHWHILE?.EUROPEAN JOURNAL OF CANCER. VOL. 46. ISSUE 10. P. 1800-1807 | 12 | 48% | 8 |
| 3 | NIIKURA, N , KIMURA, M , IWAMOTO, T , HAYASHI, N , SHINTOKU, J , SAITO, Y , SUZUKI, Y , TOKUDA, Y , (2013) WOMEN PREFER ADJUVANT ENDOCRINE THERAPY TO CHEMOTHERAPY FOR BREAST CANCER TREATMENT.BREAST CANCER. VOL. 20. ISSUE 1. P. 67-74 | 12 | 41% | 0 |
| 4 | BLINMAN, P , HUGHES, B , CROMBIE, C , CHRISTMAS, T , HUDSON, M , VEILLARD, AS , MULJADI, N , MILLWARD, M , WRIGHT, G , FLYNN, P , ET AL (2015) PATIENTS' AND DOCTORS' PREFERENCES FOR ADJUVANT CHEMOTHERAPY IN RESECTED NON-SMALL-CELL LUNG CANCER: WHAT MAKES IT WORTHWHILE?.EUROPEAN JOURNAL OF CANCER. VOL. 51. ISSUE 12. P. 1529 -1537 | 9 | 50% | 1 |
| 5 | DURIC, VM , STOCKLER, MR , HERITIER, S , BOYLE, F , BEITH, J , SULLIVAN, A , WILCKEN, N , COATES, AS , SIMES, RJ , (2005) PATIENTS' PREFERENCES FOR ADJUVANT CHEMOTHERAPY IN EARLY BREAST CANCER: WHAT MAKES AC AND CMF WORTHWHILE NOW?.ANNALS OF ONCOLOGY. VOL. 16. ISSUE 11. P. 1786-1794 | 6 | 67% | 59 |
| 6 | IIHARA, N , NISHIO, T , GODA, T , ANZAI, H , KAGAWA, M , HOUCHI, H , KIRINO, Y , (2015) EFFECT OF ENDURANCE FOR ADVERSE DRUG REACTIONS ON THE PREFERENCE FOR AGGRESSIVE TREATMENTS IN CANCER PATIENTS.SUPPORTIVE CARE IN CANCER. VOL. 23. ISSUE 4. P. 1091 -1097 | 7 | 41% | 0 |
| 7 | HAMELINCK, VC , BASTIAANNET, E , PIETERSE, AH , DE GLAS, NA , PORTIELJE, JEA , MERKUS, JWS , DEN HOED, IDM , VAN DE VELDE, CJH , LIEFERS, GJ , STIGGELBOUT, AM , (2016) A PROSPECTIVE COMPARISON OF YOUNGER AND OLDER PATIENTS' PREFERENCES FOR ADJUVANT CHEMOTHERAPY AND HORMONAL THERAPY IN EARLY BREAST CANCER.CLINICAL BREAST CANCER. VOL. 16. ISSUE 5. P. 379 -388 | 8 | 33% | 0 |
| 8 | CORICA, T , JOSEPH, D , SAUNDERS, C , BULSARA, M , NOWAK, AK , (2014) INTRAOPERATIVE RADIOTHERAPY FOR EARLY BREAST CANCER: DO HEALTH PROFESSIONALS CHOOSE CONVENIENCE OR RISK?.RADIATION ONCOLOGY. VOL. 9. ISSUE . P. - | 8 | 35% | 0 |
| 9 | CURRIE, A , ASKARI, A , NACHIAPPAN, S , SEVDALIS, N , FAIZ, O , KENNEDY, R , (2015) A SYSTEMATIC REVIEW OF PATIENT PREFERENCE ELICITATION METHODS IN THE TREATMENT OF COLORECTAL CANCER.COLORECTAL DISEASE. VOL. 17. ISSUE 1. P. 17 -25 | 9 | 26% | 4 |
| 10 | SWEENEY, KJ , RYAN, E , CANNEY, M , O'DALY, BJ , KERIN, MJ , (2007) JUSTIFYING ADJUVANT CHEMOTHERAPY IN BREAST CANCER: A SURVEY OF WOMEN AND HEALTHCARE PROFESSIONALS.EJSO. VOL. 33. ISSUE 7. P. 838-842 | 8 | 36% | 3 |
Classes with closest relation at Level 1 |